This month, the FDA approved Keytruda Qlex, a subcutaneous version of the drug that can be administered in just one to two minutes, compared to the 30-minute intravenous infusion.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Nvidia's planned $100 billion investment in OpenAI represents a historic alliance between the dominant AI GPU developer and a ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...

Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk ...

Meta Platforms is boosting business engagement with new WhatsApp tools, AI-powered features, and revenue growth momentum.

After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in ...

Stacy Knox, PharmD, BCPS, BCACP, DPLA, discusses how centralized pharmacy teams and electronic health record integration streamline prior authorizations, enhance provider efficiency, and offer ...

How long it takes for creatine to work can depend on your baseline creatine levels, consistency of use, hydration, exercise ...

High-grade gliomas are aggressive brain tumors with poor prognosis, largely because even after surgical removal, infiltrative ...

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...